Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SCH 900777 absolute bioavailability and mass balance study in healthy adult men
NL-OMON34835Active, not recruiting
- Sponsor
- Merck & Co.
- Start
- Feb 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of Org 26576 in major depressive disorder (MDD) (2 arms), sponsored by Merck & Co. Primary endpoints: Absolute bioavailability of SCH 900777, Absorption, metabolism and excretion of SCH 900777 and 3 more. Started Feb 2010; status: active, not recruiting.
02
Drugs
Org 26576
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NL-OMON34835.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34835.